Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma. - Wikidata - awgldk - TriplyDB

Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.

Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.

http://www.wikidata.org/entity/Q39484775

about

Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma MiR-133b is down-regulated in human osteosarcoma and inhibits osteosarcoma cells proliferation, migration and invasion, and promotes apoptosis.Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy.Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis.A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2 IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children's oncology group study Molecular mechanisms of chemoresistance in osteosarcoma (Review).Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma.Current therapeutic strategies and novel approaches in osteosarcoma.Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.MicroRNA-592 targets IGF-1R to suppress cellular proliferation, migration and invasion in hepatocellular carcinoma.Evaluation of the expression and role of IGF pathway biomarkers in human sarcomas.MicroRNA-184 inhibits cell proliferation and metastasis in human colorectal cancer by directly targeting IGF-1R.miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis.Molecular alterations associated with osteosarcoma development.Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer.Genetic Polymorphisms of Insulin-Like Growth Factor 1 Are Associated with Osteosarcoma Risk and Prognosis.MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1.microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R.MicroRNA-302a inhibits osteosarcoma cell migration and invasion by directly targeting IGF-1R.Molecular Signatures of the Insulin-like Growth Factor 1-mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers

P2860

Q26750631-1F2FA21B-6AEE-4ED6-AE7E-AC0D188FA940 Q35082529-3B80C6A1-F8CF-4FA6-903C-552F244E3A8A Q35894540-E79F6224-DAE7-4708-A520-1698B875D202 Q35915343-391906FA-C93A-4077-957D-791893BF3DF9 Q36029709-27300D0B-33CB-4AA8-AC7E-13342F0EF2F7 Q36085919-E027AEFD-30F1-4B6B-96FE-57F531943F73 Q37615933-53D159E9-496B-419F-987B-9C5A98B8E05C Q37624249-C77A3323-E4A8-4BE2-85CF-C1A6F0F2AE32 Q37719938-6FA9D64C-45CE-47F5-A5DD-1504CE712CF9 Q37740672-39B8DAB0-21B8-4130-9F2C-C4C0D0EC853D Q38161735-C1217366-1E67-4F7B-B61E-61753F98FB27 Q38220804-1C58CBE1-361D-4310-BAC4-FC05178658E0 Q38681107-CD29F901-AAE9-4A1D-BF3C-1F35379749F5 Q39175962-039DCE07-08B2-4E3B-8096-8B460F7EA059 Q41619346-AEAE498E-2CD4-4B65-8F26-92CA67BD2FB9 Q41975973-62F48E3A-1C19-4BA8-A71D-4A9C4EDDC71C Q42070262-F6C9E33D-60E7-4D12-8420-9B844DFE03D4 Q43144913-8F0C50E1-B19A-410C-BD91-5D2F1334F64C Q47138734-76B47B8D-2DC8-4F40-9131-D5C1A8056E42 Q49449309-8491EC7D-7CAF-462D-A596-94BB2B8E6BDC Q52595051-7C9FEC45-DEA3-4F2A-9FEC-EA3CDC3BB536 Q55261735-64B055F3-1020-4D74-A302-35CF58399ED8 Q58776408-99AD8EB8-5828-4022-AD8B-C7E10F7B29D0

P2860

Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.

http://www.wikidata.org/entity/Q39484775

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Increased expression of insuli ...... in patients with osteosarcoma.

@en

Increased expression of insuli ...... in patients with osteosarcoma.

@nl

type

label

Increased expression of insuli ...... in patients with osteosarcoma.

@en

Increased expression of insuli ...... in patients with osteosarcoma.

@nl

prefLabel

Increased expression of insuli ...... in patients with osteosarcoma.

@en

Increased expression of insuli ...... in patients with osteosarcoma.

@nl

P1433

Q39484775-AE0186F3-3188-4AFB-B692-7FD938AA3B87

P1476

Q39484775-975B9CC0-D5B6-4FBC-9169-6ADE5CBA7BA8

P2093

Q39484775-01FE7915-7E4D-4679-83DF-8FC3B8460B24

Q39484775-1142790B-F8C9-418C-9442-E45E3FEA7646

Q39484775-2A7E559D-2485-4E16-8856-252809830338

Q39484775-6DF9A459-0AD9-4497-B3DC-A9AA4085F352

Q39484775-7F0646D6-1264-4E94-B4A5-B13C7C20B5B9

Q39484775-8B0BE330-7292-4381-90E2-970EF5C2E47E

Q39484775-A95EF55D-BDA5-4A52-810A-F92EB6550E61

Q39484775-C21B2FBE-2344-4ECB-9BA8-3118E6A363CA

Q39484775-C24AEF27-6EB5-4A5C-AEDA-4AFE23D58E61

Q39484775-E42F83C4-6EFA-4C57-9139-0996A35247FE

P2860

Q39484775-00121D23-4E75-4ABB-9C51-C9D5EF06E7A4

Q39484775-2DA90D79-4699-48DE-B1B2-450C9DC5D506

Q39484775-2E01ED75-4CCA-4F72-B688-F69B862F925E

Q39484775-345313C8-F74A-4F35-B0D2-B12C4EB4BB4D

Q39484775-3A78871D-13A7-4114-98E6-87DCDC032A0A

Q39484775-3C03A004-A5F3-4378-84B6-2B5664EB3142

Q39484775-4AA1CFEA-8D88-472A-B20F-5E59A9605558

Q39484775-538AA92C-184C-44C1-8E29-6C4598C9D38E

Q39484775-5703233C-8EEB-47AB-825B-EFE306F4E19E

Q39484775-5775D8AE-92C4-4189-A225-0DBF5BF63188

P304

Q39484775-6DED425D-7C34-48DC-A67E-D90F21F91715

P31

Q39484775-2827E929-FCC2-458D-90FA-9C1D9207CD9F

P356

Q39484775-FFB36D9A-F61A-406E-8813-98A5B91729F5

P433

Q39484775-631CD45E-F16C-49A4-A135-DC5105537127

P478

Q39484775-0BD2F8B6-2EF1-495F-82E9-BDE5FE9C658B

P577

Q39484775-96A92B63-3B84-480D-8C1B-1A81DB9D6416

P698

Q39484775-0B7937CB-D56C-4919-82D0-0D4BC5CD8E35

P921

Q39484775-25BAB724-B62C-4434-88C4-E3C6297025B8

P356

P1433

Journal of Surgical Oncology

P1476

Increased expression of insuli ...... in patients with osteosarcoma.

@en

P2093

Bang-Ping Qian

http://www.w3.org/2001/XMLSchema#string

Bin Wang

http://www.w3.org/2001/XMLSchema#string

Hong-Fei Shi

http://www.w3.org/2001/XMLSchema#string

Jin Xiong

http://www.w3.org/2001/XMLSchema#string

Shou-Feng Wang

http://www.w3.org/2001/XMLSchema#string

Xiao-Dong Han

http://www.w3.org/2001/XMLSchema#string

Xu Sun

http://www.w3.org/2001/XMLSchema#string

Yang Yu

http://www.w3.org/2001/XMLSchema#string

Yi-Xin Chen

http://www.w3.org/2001/XMLSchema#string

Yin-He Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

Prognostic factors in the survival of patients diagnosed with primary non-metastatic osteosarcoma with a poor response to neoadjuvant chemotherapy.

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

Structure and function of the type 1 insulin-like growth factor receptor.

Inhibition of the type I insulin-like growth factor receptor expression and signaling: novel strategies for antimetastatic therapy.

The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis.

The insulin receptor and type I IGF receptor: comparison of structure and function.

Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment.

The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis.

The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia.

P304

235-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.22077

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21866554

http://www.w3.org/2001/XMLSchema#string

P921